微创三尖瓣手术:莱比锡三十年经验
该回顾性单中心研究纳入1996至2024年因重度三尖瓣反流行右小切口微创三尖瓣手术的成人患者,排除感染性心内膜炎、三尖瓣狭窄及同期左侧瓣膜手术者。院内死亡6%(12/199),出院时无或轻度残余反流176/194例(91%),1年、5年、10年生存率分别为85%(95%CI 80-90%)、69%(62-75%)、53%(46-61%)。
要点
- 微创三尖瓣手术中转胸骨率低(1.5%),院内死亡6%。
- 出院时91%患者无或轻度残余三尖瓣反流。
- 10年生存率53%,再手术率4%。
核心结论
- 微创三尖瓣手术治疗重度三尖瓣反流中转率低,早晚期结果良好,超过半数患者行修复。
研究设计与样本
- 回顾性单中心研究,纳入1996至2024年因重度三尖瓣反流为主要指征行右小切口微创三尖瓣手术的成人患者,排除感染性心内膜炎、三尖瓣狭窄及左侧瓣膜手术者,共199例。
主要发现
- 3例(1.5%)中转胸骨,三尖瓣修复108例(54%),院内死亡6%(12/199)。
- 出院超声无或轻度残余三尖瓣反流176/194例(91%),再手术7例(4%)。
- 估计总生存率1年85%(95%CI 80-90%)、5年69%(62-75%)、10年53%(46-61%)。
- 多变量分析中,年龄较大、男性、急诊/紧急手术、心房颤动/扑动、糖尿病、右心衰体征、较低肾小球滤过率和较低术前血红蛋白独立预测死亡。
临床怎么用
- 对于重度三尖瓣反流,右小切口微创三尖瓣手术中转率低,可作为可选术式,修复比例超过半数。
- 术前应评估年龄、性别、手术紧迫性、心房颤动/扑动、糖尿病、右心衰体征、肾小球滤过率和血红蛋白等死亡预测因素。
局限性
- 回顾性单中心设计可能限制结果外推。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Data on minimally invasive tricuspid valve surgery for severe tricuspid regurgitation remain limited, particularly regarding long-term outcomes. METHODS: This retrospective single-center study included adult patients who underwent minimally invasive tricuspid valve surgery through right mini-thoracotomy for severe tricuspid regurgitation as the primary indication between 1996 and 2024. Patients with endocarditis or tricuspid stenosis, as well as those undergoing left-sided valve surgery, were excluded. The primary endpoint was all-cause mortality during follow-up. RESULTS: A total of 199 patients with a median age of 70.0 years, including 110 (55%) women, were analyzed. Sixty-four (32%) had previous cardiac surgery. Median EuroSCORE II was 3.6% (1.8-6.0) and median TRI-SCORE-predicted mortality was 5.0% (3.0-14.0). Three patients (1.5%) required conversion to sternotomy. Tricuspid valve repair was performed in 108 patients (54%). In-hospital mortality was 6% for the entire cohort (12/199). Discharge echocardiography demonstrated no or mild residual tricuspid regurgitation in 176/194 patients (91%). Estimated overall survival was 85% (95% confidence interval, 80-90%) at 1 year, 69% (62-75%) at 5 years, and 53% (46-61%) at 10 years. Repeat tricuspid valve surgery was recorded in 7 patients (4%). In multivariable analysis, older age, male sex, urgent/emergent operation, atrial fibrillation/flutter, diabetes mellitus, signs of right heart failure, lower glomerular filtration rate and lower preoperative hemoglobin independently predicted mortality. CONCLUSIONS: Minimally invasive tricuspid valve surgery for severe tricuspid regurgitation was associated with low conversion rates and provided good early and late outcomes. Repair was performed in over half of patients.
引用
- Mazur P, Papakonstantinou K, Kang J, et al. Minimally-invasive tricuspid valve operations: three decades of Leipzig experience. Eur J Cardiothorac Surg. 2026. PMID: 42836706. doi:10.1093/ejcts/ezag238
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。